DICE Therapeutics
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of DICE Therapeutics generated cash of -$64,322,000, which is less than the previous year. Cash used in financing activities reached the amount of $322,252,000 last year. Net change in cash is therefore $345,417,000.
Cash Flow
| 2019 | -16.29M | -19.13M | -278K |
|---|---|---|---|
| 2020 | -20.67M | 18.00M | 53.89M |
| 2021 | -39.29M | -204.62M | 300.25M |
| 2022 | -64.32M | 87.48M | 322.25M |
DICE Cash Flow Statement (2019 – 2022)
| 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|
Cash at beginning of period | 116.17M | 59.83M | 8.61M | 44.32M |
Operating activities | ||||
Net income | -83.88M | -48.95M | -23.73M | -12.93M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||
Depreciation and amortization | 2.42M | 661K | 697K | 706K |
Stock-based compensation expense | 12.82M | 5.58M | 556K | 529K |
| Deferred income tax benefit | 12.82M | 5.58M | 556K | 529K |
| Changes in operating assets and liabilities: | ||||
Accounts receivable, net | 1.5M | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 |
Accounts payable | 1.33M | -772K | 1.41M | 289K |
Cash generated by operating activities | -64.32M | -39.29M | -20.67M | -16.29M |
Investing activities | ||||
Purchases Of Investments | -139.25M | -218.47M | -3.64M | -39.77M |
Investments In Property Plant And Equipment | -2.23M | -718K | -148K | -981K |
Acquisitions Net | 0 | 0 | 0 | 0 |
Cash generated by investing activities | 87.48M | -204.62M | 18.00M | -19.13M |
Financing activities | ||||
Common Stock Issued | 323.71M | 214.70M | 0 | 0 |
Payments for dividends | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | -99K | -122K | 0 |
Cash used in financing activities | 322.25M | 300.25M | 53.89M | -278K |
Net Change In Cash | 345.41M | 56.33M | 51.21M | -35.70M |
Cash at end of period | 461.59M | 116.17M | 59.83M | 8.61M |
| Data source | Data source |